Antigenics, Inc

Vion Pharmaceuticals Inc.


4 Science Park
New Haven, CT 06511

USA


Phone: (203) 498-4210
Fax: (203) 498-4211
Email: cswearngan@burnsmc.com
Web Site: http://www.vionpharm.com/

 

A. Company Profile

 

Vion (NASDAQ:VION) is a biotechnology company developing novel agents for the treatment of cancer.

 

B. Products

 

 

Product Pipelines

 

 

Product

 

 

Indication

 

Clinical Status

 

Triapine

 

Various tumors

 

Phase II

 

Cloretazine (VNP40101M)

 

Various tumors

 

Phase II

 

1. Triapine

 

Triapineis a potent inhibitor of ribonucleotide reductase, an enzyme important for DNA synthesis.

 

2. Cloretazine

 

Cloretazine, VNP40101M, is a unique DNA alkylating agent.